The Experts below are selected from a list of 1332 Experts worldwide ranked by ideXlab platform
Tone E G Henriksen - One of the best experts on this subject based on the ideXlab platform.
-
blue blocking glasses as additive treatment for mania effects on actigraphy derived Sleep parameters
Journal of Sleep Research, 2020Co-Authors: Tone E G Henriksen, Janne Gronli, Jorg Assmus, Ole Bernt Fasmer, Helle K Schoeyen, Ieva Leskauskaite, Jeanette BjorkebertheussenAbstract:Improvement of Sleep is a central treatment goal for patients in a manic state. Blue-blocking (BB) glasses as adjunctive treatment hasten overall recovery from mania. This method is an evolvement from dark therapy and builds on the discovery of the blue-light-sensitive retinal ganglion cell that signals daytime to the brain. We report effects of adjunctive BB glasses on actigraphy-derived Sleep parameters for manic inpatients as compared to placebo. Hospitalized patients with bipolar disorder in a manic state aged 18-70 years were recruited from five clinics in Norway from February 2012 to February 2015. The participants were randomly allocated to wearing BB glasses or placebo (clear glasses) as an adjunctive treatment from 18:00 to 08:00 hours for seven consecutive nights. Sleep and wake were monitored by actigraphy. From 32 eligible patients, 10 patients in each group qualified for the group analyses. The BB group's mean Sleep efficiency was significantly higher at night 5 as compared to the placebo group (92.6% vs. 83.1%, p = .027). The 95% confidence interval (CI) was 89.4%-95.8% in the BB group and 75.9%-90.3% in the placebo group. There were fewer nights of Interrupted Sleep in the BB group: 29.6% versus 43.8% in the placebo group. The BB group received less-intensive Sleep-promoting pharmacological treatment and showed significantly higher Sleep efficiency and more consolidated Sleep as compared to the placebo group. Our findings suggest Sleep-promoting effects through deactivating mechanisms. Adjunctive BB glasses seem to be useful for improving Sleep for manic patients in the hospital setting.
Jeanette Bjorkebertheussen - One of the best experts on this subject based on the ideXlab platform.
-
blue blocking glasses as additive treatment for mania effects on actigraphy derived Sleep parameters
Journal of Sleep Research, 2020Co-Authors: Tone E G Henriksen, Janne Gronli, Jorg Assmus, Ole Bernt Fasmer, Helle K Schoeyen, Ieva Leskauskaite, Jeanette BjorkebertheussenAbstract:Improvement of Sleep is a central treatment goal for patients in a manic state. Blue-blocking (BB) glasses as adjunctive treatment hasten overall recovery from mania. This method is an evolvement from dark therapy and builds on the discovery of the blue-light-sensitive retinal ganglion cell that signals daytime to the brain. We report effects of adjunctive BB glasses on actigraphy-derived Sleep parameters for manic inpatients as compared to placebo. Hospitalized patients with bipolar disorder in a manic state aged 18-70 years were recruited from five clinics in Norway from February 2012 to February 2015. The participants were randomly allocated to wearing BB glasses or placebo (clear glasses) as an adjunctive treatment from 18:00 to 08:00 hours for seven consecutive nights. Sleep and wake were monitored by actigraphy. From 32 eligible patients, 10 patients in each group qualified for the group analyses. The BB group's mean Sleep efficiency was significantly higher at night 5 as compared to the placebo group (92.6% vs. 83.1%, p = .027). The 95% confidence interval (CI) was 89.4%-95.8% in the BB group and 75.9%-90.3% in the placebo group. There were fewer nights of Interrupted Sleep in the BB group: 29.6% versus 43.8% in the placebo group. The BB group received less-intensive Sleep-promoting pharmacological treatment and showed significantly higher Sleep efficiency and more consolidated Sleep as compared to the placebo group. Our findings suggest Sleep-promoting effects through deactivating mechanisms. Adjunctive BB glasses seem to be useful for improving Sleep for manic patients in the hospital setting.
Helle K Schoeyen - One of the best experts on this subject based on the ideXlab platform.
-
blue blocking glasses as additive treatment for mania effects on actigraphy derived Sleep parameters
Journal of Sleep Research, 2020Co-Authors: Tone E G Henriksen, Janne Gronli, Jorg Assmus, Ole Bernt Fasmer, Helle K Schoeyen, Ieva Leskauskaite, Jeanette BjorkebertheussenAbstract:Improvement of Sleep is a central treatment goal for patients in a manic state. Blue-blocking (BB) glasses as adjunctive treatment hasten overall recovery from mania. This method is an evolvement from dark therapy and builds on the discovery of the blue-light-sensitive retinal ganglion cell that signals daytime to the brain. We report effects of adjunctive BB glasses on actigraphy-derived Sleep parameters for manic inpatients as compared to placebo. Hospitalized patients with bipolar disorder in a manic state aged 18-70 years were recruited from five clinics in Norway from February 2012 to February 2015. The participants were randomly allocated to wearing BB glasses or placebo (clear glasses) as an adjunctive treatment from 18:00 to 08:00 hours for seven consecutive nights. Sleep and wake were monitored by actigraphy. From 32 eligible patients, 10 patients in each group qualified for the group analyses. The BB group's mean Sleep efficiency was significantly higher at night 5 as compared to the placebo group (92.6% vs. 83.1%, p = .027). The 95% confidence interval (CI) was 89.4%-95.8% in the BB group and 75.9%-90.3% in the placebo group. There were fewer nights of Interrupted Sleep in the BB group: 29.6% versus 43.8% in the placebo group. The BB group received less-intensive Sleep-promoting pharmacological treatment and showed significantly higher Sleep efficiency and more consolidated Sleep as compared to the placebo group. Our findings suggest Sleep-promoting effects through deactivating mechanisms. Adjunctive BB glasses seem to be useful for improving Sleep for manic patients in the hospital setting.
Ole Bernt Fasmer - One of the best experts on this subject based on the ideXlab platform.
-
blue blocking glasses as additive treatment for mania effects on actigraphy derived Sleep parameters
Journal of Sleep Research, 2020Co-Authors: Tone E G Henriksen, Janne Gronli, Jorg Assmus, Ole Bernt Fasmer, Helle K Schoeyen, Ieva Leskauskaite, Jeanette BjorkebertheussenAbstract:Improvement of Sleep is a central treatment goal for patients in a manic state. Blue-blocking (BB) glasses as adjunctive treatment hasten overall recovery from mania. This method is an evolvement from dark therapy and builds on the discovery of the blue-light-sensitive retinal ganglion cell that signals daytime to the brain. We report effects of adjunctive BB glasses on actigraphy-derived Sleep parameters for manic inpatients as compared to placebo. Hospitalized patients with bipolar disorder in a manic state aged 18-70 years were recruited from five clinics in Norway from February 2012 to February 2015. The participants were randomly allocated to wearing BB glasses or placebo (clear glasses) as an adjunctive treatment from 18:00 to 08:00 hours for seven consecutive nights. Sleep and wake were monitored by actigraphy. From 32 eligible patients, 10 patients in each group qualified for the group analyses. The BB group's mean Sleep efficiency was significantly higher at night 5 as compared to the placebo group (92.6% vs. 83.1%, p = .027). The 95% confidence interval (CI) was 89.4%-95.8% in the BB group and 75.9%-90.3% in the placebo group. There were fewer nights of Interrupted Sleep in the BB group: 29.6% versus 43.8% in the placebo group. The BB group received less-intensive Sleep-promoting pharmacological treatment and showed significantly higher Sleep efficiency and more consolidated Sleep as compared to the placebo group. Our findings suggest Sleep-promoting effects through deactivating mechanisms. Adjunctive BB glasses seem to be useful for improving Sleep for manic patients in the hospital setting.
Riggio F. - One of the best experts on this subject based on the ideXlab platform.
-
Bipolar Quantum Molecular Resonance versus Blunt Dissection tonsillectomy
Koninklijke Belgische Vereniging voor ORL Gelaat en Halschirugie, 2015Co-Authors: Lorusso F., Di Salvo N, Gallina S., Modica D., Riggio F.Abstract:Bipolar Quantum Molecular Resonance versus Blunt Dissection tonsillectomy. Objectives: This study compared a quantum molecular resonance tonsillectomy (QMRT) to a standard blunt dissection tonsillectomy (BDT) for effectiveness and safety. Methodology: From January 2011 to September 2012, we recruited 80 children (ages 3 to 16 y) with paediatric obstructive Sleep apnoea syndrome and/or recurrent tonsillitis. Patients were randomly assigned to receive QMRT (N = 40) or BDT (N = 40). The operating time and blood loss during surgery were evaluated. During the first postoperative week, the patients' parents completed a questionnaire to evaluate bleeding, ear and neck pain, nausea, vomiting, Interrupted Sleep, oral liquid intake or discomfort in fluid assumption, and analgesic consumption. Results: The average tonsillectomy duration was significantly shorter in the QMRT group (22.07 min \ub1 9.05) than in the BDT group (35.12 min \ub1 13.32; p < 0.000005). The average blood loss during tonsillectomy was significantly lower for the QMRT group (5.62 ml \ub1 7.44) than for the BDT group (43 ml \ub1 33.20; p < 000000001). However, the BDT group reported significantly lower pain scores than the QMRT group on days 2 (p < 0.05), 5 (p < 0.05), and 6 (p < 0.05); on other days, the groups were not significantly different. The BDT group reported two early and one late bleeding episodes; the QMRT group recorded only two late bleeding episodes. Conclusions: QMRT significantly reduced the operating time and intra-operative blood loss. No significant differences were found between the two techniques in postoperative pain or bleeding
